The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4.
Abstract
The HLA-G primary transcript is alternatively spliced to yield mRNAs encoding three alternative membrane bound proteins. In addition to these forms, a soluble HLA-G protein has been described which is not encoded directly by any of the three alternative mRNAs. To explain the process which might lead to the expression of a soluble HLA-G Ag, we investigated the potential roles proteolytic processing and additional alternative splicing of HLA-G RNA might play. By generating transfected cells with HLA-G cDNA expression driven by a retroviral promoter, it was possible to rule out proteolytic processing of the membrane-bound HLA-G as a mechanism of generating soluble HLA-G, resulting in our focus on alternative splicing as an explanation. Analysis of PCR-amplified cDNA revealed a relatively abundant transcript present in all samples examined which consisted of the full length HLA-G mRNA sequence interrupted by intron 4 sequence. The open reading frame in this mRNA continues into intron 4 terminating 21 amino acids after the alpha 3 domain, thus excluding the transmembrane encoding region and yielding a protein with a highly charged carboxyl terminus. Transfection of the intron 4 containing cDNA, inserted into a retroviral expression vector, into LCL .221 followed by comparison of the class I protein to native soluble G by two dimensional isoelectric focusing/SDS-PAGE analysis, demonstrated this message encoded the soluble HLA-G protein. In addition, a similar intron containing message derived from the HLA-G2 mRNA was found, suggesting the existence of a soluble form of this alternative HLA-G protein. These findings are discussed in relation to other soluble class I molecules and with regard to potential functions of the soluble HLA-G Ag.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
[2] New M13 vectors for cloning
Messing, J. (1983) · Methods in Enzymology · doi:10.1016/0076-6879(83)01005-8 · Cited by 5,323
ALTERNATIVE SPLICING IN THE CONTROL OF GENE EXPRESSION
Smith, C. W. J., Patton, J. G., & Nadal-Ginard, B. (1989) · Annual Review of Genetics · doi:10.1146/annurev.ge.23.120189.002523 · Cited by 692
Major histocompatibility antigens: The human (HLA-A,-B,-C) and murine (H-2K, H-2D) class I molecules
Ploegh, H. L., Orr, H. T., & Strominger, J. L. (1981) · Cell · doi:10.1016/0092-8674(81)90318-4 · Cited by 520
Ishitani, A., & Geraghty, D. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.3947 · Cited by 515
Self-citationSpies, T., Cerundolo, V., Colonna, M., Cresswell, P., Townsend, A., & DeMars, R. (1992) · Nature · doi:10.1038/355644a0 · Cited by 321
HLA-E. A novel HLA class I gene expressed in resting T lymphocytes.
Koller, B. H., Geraghty, D. E., Shimizu, Y., DeMars, R., & Orr, H. T. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.3.897 · Cited by 245
Self-citationSecretion of HLA-A and -B antigens via an alternative RNA splicing pathway.
Krangel, M. S. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.5.1173 · Cited by 216
Leppard, K. N., & Shenk, T. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08360.x · Cited by 166
Molecules Related To Class-I Major Histocompatibility Complex Antigens
Stroynowski, I. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.002441 · Cited by 143
Porto, J. D., Johansen, T. E., Čatipović, B., Parfiit, D. J., Tuveson, D. A., Gether, U., Kozlowski, S., Fearon, D. T., & Schneck, J. P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6671 · Cited by 141
Cited by
MECHANISMS OF MHC CLASS I–RESTRICTED ANTIGEN PROCESSING
Pamer, E., & Cresswell, P. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.323 · Cited by 1,008
HLA‐G and immune tolerance in pregnancy
Hunt, J. S., Petroff, M. G., McIntire, R. H., & Ober, C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2078rev · Cited by 524
Lee, N., Goodlett, D. R., Ishitani, A., Marquardt, H., & Geraghty, D. E. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.4951 · Cited by 505
Self-citationFournel, S., Aguerre-Girr, M., Huc, X., Lenfant, F., Alam, A., Toubert, A., Bensussan, A., & Le Bouteiller, P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6100 · Cited by 463
IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes
Moreau, P., Adrian-Cabestre, F., Menier, C., Guiard, V., Gourand, L., Dausset, J., Carosella, E. D., & Paul, P. (1999) · International Immunology · doi:10.1093/intimm/11.5.803 · Cited by 411
Ishitani, A., Sageshima, N., Lee, N., Dorofeeva, N., Hatake, K., Marquardt, H., & Geraghty, D. E. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.3.1376 · Cited by 377
Self-citationHLA-G Molecules: from Maternal–Fetal Tolerance to Tissue Acceptance
CAROSELLA, E. D., MOREAU, P., LE MAOULT, J., LE DISCORDE, M., DAUSSET, J., & ROUAS-FREISS, N. (2003) · Advances in Immunology · doi:10.1016/s0065-2776(03)81006-4 · Cited by 371
Donadi, E. A., Castelli, E. C., Arnaiz-Villena, A., Roger, M., Rey, D., & Moreau, P. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0580-7 · Cited by 362
Contini, P., Ghio, M., Poggi, A., Filaci, G., Indiveri, F., Ferrone, S., & Puppo, F. (2003) · European Journal of Immunology · doi:10.1002/immu.200390015 · Cited by 358
Activation of NK Cells by an Endocytosed Receptor for Soluble HLA-G
Rajagopalan, S., Bryceson, Y. T., Kuppusamy, S. P., Geraghty, D. E., Meer, A. V. D., Joosten, I., & Long, E. O. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0040009 · Cited by 353
Self-citationHviid, T. V. F., Hylenius, S., Rørbye, C., & Nielsen, L. G. (2003) · Immunogenetics · doi:10.1007/s00251-003-0547-z · Cited by 349
HLA-G in human reproduction: aspects of genetics, function and pregnancy complications
Hviid, T. V. F. (2006) · Human Reproduction Update · doi:10.1093/humupd/dmi048 · Cited by 332
Riteau, B., Rouas-Freiss, N., Menier, C., Paul, P., Dausset, J., & Carosella, E. D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.5018 · Cited by 324
Lila, N., Rouas-Freiss, N., Dausset, J., Carpentier, A., & Carosella, E. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201407398 · Cited by 314
Lee, N., Malacko, A. R., Ishitani, A., Chen, M.-C., Bajorath, J., Marquardt, H., & Geraghty, D. E. (1995) · Immunity · doi:10.1016/1074-7613(95)90130-2 · Cited by 312
Self-citationStrong, R. K., Holmes, M. A., Li, P., Braun, L., Lee, N., & Geraghty, D. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208268200 · Cited by 308
Self-citationHLA‐G up‐regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells
Lemaoult, J., Zafaranloo, K., Le Danff, C., & Carosella, E. D. (2005) · The FASEB Journal · doi:10.1096/fj.04-1617fje · Cited by 302
Ariga, H., Ohto, H., Busch, M. P., Imamura, S., Watson, R., Reed, W., & Lee, T. (2001) · Transfusion · doi:10.1046/j.1537-2995.2001.41121524.x · Cited by 277
Nicolae, D., Cox, N. J., Lester, L. A., Schneider, D., Tan, Z., Billstrand, C., Kuldanek, S., Donfack, J., Kogut, P., Patel, N. M., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/427763 · Cited by 254
Cellular senescence induced by CD158d reprograms natural killer cells to promote vascular remodeling
Rajagopalan, S., & Long, E. O. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208248109 · Cited by 168
Metadata
- Authors
- Fujii, T., Ishitani, A., & Geraghty, D. E.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1994-12
- Volume
- 153
- Issue
- 12
- Pages
- 5516-5524
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2142828345
- Cited by
- 362
- References
- 19
- FWCI
- 4.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.